Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000880983 | SCV001024118 | benign | not provided | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002478998 | SCV002794749 | likely benign | Complement component 5 deficiency; Eculizumab, poor response to | 2022-01-17 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003940425 | SCV004749619 | likely benign | C5-related disorder | 2019-07-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |